Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Triple Negative Breast Neoplasms 27 Neoplasm Metastasis 18 Sarcoma 17 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 6 Brain Neoplasms 5 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 HER2-negative Breast Cancer 3 Carcinoma, Transitional Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Melanoma 2 Lymphoma 2 Lung Neoplasms 2 Leiomyosarcoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Advanced Breast Cancer 2

Interventions

eribulin 1 Radiotherapy 1 Metformin 1 Hypoglycemic Agents 1 Diet, Carbohydrate-Restricted 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ketosis × eribulin × Clear all

NCT02061085 2025-06-08

MERIBEL

MedSIR

Phase 2 Completed

53 enrolled 11 charts

Breast Neoplasms, Ketosis, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡